Member Info for nomlungu

and the lunch will be paid for by the kind hearted liquidators

amazing!

did you not see the hint of sarcasm - the last rns did state the distribution to shareholders is expected to be nil

normally only well run companies who are trusted by the market have such a low spread

and then I am going to put it all into AIQ - exciting days ahead

I know the bod have said the shares are worthless but as this is aim so maybe 6p today imo, dyor etc

It is a Basil- faulty fractures needing stimulation.

I am a bit confused why you reply more than once after stating you would only post once to me. Nonetheless, you do not answer the question. Val are an early stage AIM cancer share that needs a cash flow to continue - unless approved by current shareholders no more funds can be raised through a placing[s]. To progress funding is needed - maybe the mythical take over happens [would you really want the board to leave as they are the scientists behind this approach}. Time will tell...

The last quarterly RNS was issued on the 20th of February so an update should arrive soon (imo).

Baron Oil have issued an RNS titled Wick and Colter Revised Well Costs and Resources - strange they are down 10 percent and RBD are up 3.57 percent - the mystery of AIM share prices baffles me some days.

I only want a little over 1 p so please keep ramping

IMO etc, Will there be an outsider who steps up? Will there be dilution?

Posting links from medscape is questionable: https://www.medscape.com/public/termsofuse Use of the Services The Services are intended for physicians and other healthcare professionals. By using the Services, you represent and warrant that you have the right, authority, and capacity to agree to and abide by these Terms and that you are not prohibited from using the Services or any portion thereof. Maybe I am deluded... Are you a physician or a healthcare professional?

Geecee3, Do you have any scientific knowledge? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557960/

great ramp for so little posts; imo, dyor etc

I thought a deal was expected?

No ramp - some on this bb profess scientific knowledge so I kicked the can down the road to read the replies to my question?

I read the article below which led me ABC [Abcam]. Any thoughts? https://www.motherjones.com/environment/2018/05/the-best-viral-news-youll-ever-read-antibiotic-resistance-phage-therapy-bacteriophage-virus/

isas, The practice of phage therapy uses bacterial viruses (phages) to treat bacterial infections - these links may be of interest. The current top youtube video is an 'idiots guide' https://www.youtube.com/results?search_query=Bacteriophage https://en.wikipedia.org/wiki/Phage_therapy https://www.motherjones.com/environment/2018/05/the-best-viral-news-youll-ever-read-antibiotic-resistance-phage-therapy-bacteriophage-virus/ It is an interesting area of research; the Mother Jones article spiked my recent interest and lead me to another share that I am considering buying into [abcam]. IMO, DYOR etc...

I have been reading about phage therapy and was surprised to see that Tbilisi is a centre of expertise - it is also where 401 is being trailed. IMO; DYOR etc...